REINVENTING HOW HEALTHCARE PROFESSIONALS AND PATIENTS MANAGE PAIN
VIRPAX Pharmaceuticals is committed to developing products that effectively manage pain and all its complexities, while minimizing risks to patients and society. Pain is a universal condition, while the perception of pain is unique.
We are dedicated to creating novel treatment options for the management of pain. By combining innovative drug compounds with cutting-edge delivery systems, we strive to maximize our products’ capabilities and successfully bring them to market.
NON-ADDICTIVE PRODUCTS
We are developing numerous strategies that will address the rising need for alternatives to addictive opioid prescription medications. Our non-addictive products harness the improved characteristics of transdermal and liposomal drug-delivery technologies to target pain at its source. By focusing on these new drug-loaded delivery systems, we aim to increase product compliance and maximize the ability to achieve full therapeutic efficacy.
DEVELOPING BETTER OPTIONS
Our main purpose is to provide healthcare professionals and patients with new effective solutions to manage and control pain, whether acute or chronic, and to do so quickly in order to facilitate better practices for pain management worldwide.
“Biopharma companies have a deep understanding of the R&D of novel products, making the industry essential to the advancement of public health initiatives.”
ANTHONY P. MACK
CEO of VIRPAX Pharmaceuticals
INNOVATIVE TECHNOLOGIES
Utilizing the latest medical advancements, our innovative molecular technologies are being developed to increase compliance and maximize the patient’s ability to achieve full therapeutic efficacy.
REINVENTING PAIN RELIEF
Transdermal and topical delivery systems will reinvent how patients and prescribers manage pain worldwide. We are developing novel compounds and adding innovation to established FDA approved treatments with improved formulations and better attributes.
FUTURE GROWTH POTENTIAL
We believe that this topical metered-dose spray technology could provide a pathway for additional proprietary spray formulations for us going forward. These additional indications include estrogen levels, Alzheimer’s disease, dementia, Parkinson’s disease, neuropathic issues, and acute and chronic pain.
We are developing novel drug delivery systems and continuously seeking patents in various therapeutic areas.